Literature DB >> 1636381

Tubuloreticular structures in microglial cells, pericytes and endothelial cells in Alzheimer's disease.

J Wegiel1, H M Wisniewski.   

Abstract

In two of six brain biopsies of patients with Alzheimer's disease (AD), tubuloreticular structures (TRS) were observed in the distended endoplasmic reticulum of microglial cells, endothelial cells of vessels, and pericytes. In the microglial cells that produce amyloid fibrils, TRS were found in the cytoplasmic channels, which were filled with newly formed amyloid fibrils. Co-localization of TRS and newly formed amyloid fibrils in the same cellular compartment strengthens the hypothesis that amyloid fibrils are formed in the endoplasmic reticulum of microglial cells. Formation of TRS in microglial cells, pericytes, and endothelial cells of vessels probably reflects local or systemic alpha-interferon production. In some cells, this pathological process coexists with the second type of pathological changes: formation of amyloid fibrils.

Entities:  

Mesh:

Year:  1992        PMID: 1636381     DOI: 10.1007/bf00299416

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Abnormal structures in circulating lymphocytes from patients with systemic lupus erythematosus and related diseases.

Authors:  P M Grrimley; J L Decker; H J Michelitch; M M Frantz
Journal:  Arthritis Rheum       Date:  1973 May-Jun

2.  Immunoglobulin synthesis and tubular arrays in the endoplasmic reticulum in transplanted human tumors of lymphoid origin.

Authors:  L Pothier; B G Uzman; M M Kasac; H Saito; R A Adams
Journal:  Lab Invest       Date:  1973-12       Impact factor: 5.662

3.  Tubular aggregates in endoplasmic reticulum in herpes-simplex encephalitis.

Authors:  J R Baringer
Journal:  N Engl J Med       Date:  1971-10-21       Impact factor: 91.245

4.  Hepatic inclusions during interferon therapy in chronic viral hepatitis.

Authors:  Z Schaff; J H Hoofnagle; P M Grimley
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

5.  Immune interferon does not stimulate formation of alpha and beta interferon induced human lupus-type inclusions.

Authors:  S A Rich; T R Owens; L E Bartholomew; J U Gutterman
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

6.  Tubuloreticular inclusions in placental chorionic villi of rhesus monkeys after maternal treatment with interferon.

Authors:  D Feldman; R M Hoar; W H Niemann; T Valentine; M Cukierski; A G Hendrickx
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

7.  Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia).

Authors:  G G Glenner
Journal:  Med Hypotheses       Date:  1979-11       Impact factor: 1.538

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion.

Authors:  C Haass; A Y Hung; D J Selkoe
Journal:  J Neurosci       Date:  1991-12       Impact factor: 6.167

10.  Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie.

Authors:  H M Wisniewski; A W Vorbrodt; J Wegiel; J Morys; A S Lossinsky
Journal:  Am J Med Genet Suppl       Date:  1990
View more
  2 in total

1.  The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival.

Authors:  Drew Bonkowski; Vladimir Katyshev; Roumen D Balabanov; Andre Borisov; Paula Dore-Duffy
Journal:  Fluids Barriers CNS       Date:  2011-01-18

2.  Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide.

Authors:  Andrej Kovac; Michelle A Erickson; William A Banks
Journal:  J Neuroinflammation       Date:  2011-10-13       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.